Media Centre
Latest press releases
-
AstraZeneca provides update on the Phase III MYSTIC trial of Imfinzi and tremelimumab in Stage IV non-small cell lung cancer
-
AstraZeneca to divest US Synagis rights to Sobi
-
US FDA accepts regulatory submission for Lynparza maintenance therapy in newly-diagnosed, BRCA-mutated advanced ovarian cancer and grants Priority Review
-
Farxiga significantly reduced hospitalisation for heart failure or CV death in a broad patient population with type-2 diabetes in the landmark DECLARE-TIMI 58 trial
-
Year-To-Date and Q3 2018 Results
Medical Releases
These press releases are specifically for health specialist/medical media and are not for consumer press.
Contact us
Karen Birmingham
Director Global Science Media
Rob Skelding
Director Global Media Relations
Matthew Kent
Director Global Media Relations
Gonzalo Viña
Director Global Media Relations
Jennifer Hursit
Manager Global Media Relations
Jacob Lund
Director External Communications, Sweden
Lotta Sjösten
Manager Media Relations, Sweden
US Media Team
